Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme advances 2nd Gaucher drug
Bizjournals.com
Friday, February 18, 2011 - 3:22pm
tags:
Gaucher disease, Genzyme
Watson’s Bisaro Tells CNBC Generic Lipitor to Be ‘Huge Product’
Bloomberg
Friday, February 18, 2011 - 3:20pm
tags:
Watson Pharmaceuticals, Paul Bisaro, generics, Lipitor, Pfizer
Impax Laboratories gets FDA approval for generic version of antibiotic Adoxa
Yahoo/AP
Friday, February 18, 2011 - 3:19pm
tags:
Impax, FDA, generics, antibiotics, Adoxa
Obama asks judge for clarity on health care ruling
Bizjournals.com
Friday, February 18, 2011 - 3:18pm
tags:
Obama, healthcare reform
PDL Settles MedImmune Dispute
Yahoo/Zacks.com
Friday, February 18, 2011 - 3:17pm
tags:
PDL Biopharma, MedImmune, AstraZeneca, RSV, Synagis, Abbott Laboratories
Investors scour biotechs in search of the next big payoff
Fierce Biotech
Friday, February 18, 2011 - 9:40am
tags:
investors, biotech, Dendreon, Human Genome Sciences, Biomarin, Alexion
How Many New Drugs Did FDA Approve Last Year?
Pharmalot
Friday, February 18, 2011 - 9:37am
tags:
FDA, drug approvals
Biotech Mailbag: BIO CEO Wrap
TheStreet.com
Friday, February 18, 2011 - 9:36am
tags:
BIO CEO Conference, Rexahn, Nymox, MannKind, Teva Pharmaceuticals, Somaxon, Medivation, Cell Therapeutics, YM BioSciences
Good News for Dendreon's Provenge
Seeking Alpha
Friday, February 18, 2011 - 9:33am
tags:
Provenge, prostate cancer, Dendreon, vaccines
What Sanofi-Genzyme Means for the Rest of Biotech
Motley Fool
Friday, February 18, 2011 - 9:32am
tags:
biotech, Sanofi, Genzyme, M&A
BioMarin Pharma reports 4Q loss on costs
Yahoo/AP
Friday, February 18, 2011 - 9:31am
tags:
earnings, Biomarin
Cramer's Mad Money - Big Pharma Is One Big Graveyard for Stocks
Seeking Alpha
Friday, February 18, 2011 - 9:24am
tags:
Allergan, Bristol-Myers Squibb, Express Scripts, GSK, Eli Lilly, Merck, Pfizer
Pfizer: Little Downside Risk, But Not That Much Upside
Seeking Alpha
Friday, February 18, 2011 - 9:19am
tags:
Pfizer
[video] Johnson & Johnson CEO on Road Ahead
CNBC
Friday, February 18, 2011 - 9:18am
tags:
JNJ, Pharma CEOs, William Weldon
Sanofi/Genzyme: The Hard Work Begins
InVivo
Thursday, February 17, 2011 - 1:44pm
tags:
Sanofi, Genzyme, M&A
Earnings Scorecard: Life Technologies
Yahoo/Zacks.com
Thursday, February 17, 2011 - 1:19pm
tags:
earnings, Life Technologies
Sales reps say medical knowledge, business acumen are keys to access
Medical Marketing & Media
Thursday, February 17, 2011 - 1:07pm
tags:
drug reps
Nurse Practitioners Like Pharma Lunches & Dinners
Pharmalot
Thursday, February 17, 2011 - 1:05pm
tags:
nurse practitioners, drug reps
Endo Pharma Starts Cancer Trial
Yahoo/Zacks.com
Thursday, February 17, 2011 - 1:04pm
tags:
Endo, Bioniche Pharma, Urocidin, Spectrum Pharmaceuticals
Inspire beats Street with 4Q, 2010 earnings, revenue
Bizjournals.com
Thursday, February 17, 2011 - 1:03pm
tags:
Inspire, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.